# Wefunder

hosted live 2026 Reg CF campaigns for companies including Mahzi Therapeutics (gene therapy for Pitt Hopkins Syndrome and related rare neurodevelopmental disorders) and Eliaz Therapeutics (its XGal-3 apheresis device targeting sepsis via Galectin-3 removal).

Source: https://en.bioecon.ru/companies/wefunder/
Updated: 2026-07-04

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $60 million total prior capital raised from venture capital investors | https://biobase.whitefordresearch.com/companies/mahzi-therapeutics, https://kingscrowd.com/mahzi-therapeutics-on-wefunder-2026/, https://thenyledger.com/business/rare-disease-families-can-now-invest-in-biotech-gene-therapy/ |
| Funding | $16 million in cumulative grant awards from the California Institute for Regenerative Medicine (CIRM) | https://biobase.whitefordresearch.com/companies/mahzi-therapeutics, https://kingscrowd.com/mahzi-therapeutics-on-wefunder-2026/, https://thenyledger.com/business/rare-disease-families-can-now-invest-in-biotech-gene-therapy/ |
| Funding | 2026 Regulation Crowdfunding (Reg CF) offering on Wefunder with a target of $50,000 and a maximum of $1.2 million | http://biobase.whitefordresearch.com/companies/mahzi-therapeutics, https://biobase.whitefordresearch.com/companies/mahzi-therapeutics, https://kingscrowd.com/mahzi-therapeutics-on-wefunder-2026/, https://wefunder.com/mahzi.therapeutics |
| Headcount | 14 to 17 employees | https://kingscrowd.com/mahzi-therapeutics-on-wefunder-2026/ |
| Revenue | $0 as of fiscal year 2025 | https://kingscrowd.com/mahzi-therapeutics-on-wefunder-2026/ |
| Regulatory approval | FDA Orphan Drug Designation, Fast Track Designation, and Rare Pediatric Disease Designation for MZ-1866 | https://www.biopharminternational.com/view/fda-grants-rare-pediatric-disease-designation-to-mahzi-s-aav9-gene-therapy-mz-1866-for-pitt-hopkins-syndrome, https://www.prnewswire.com/news-releases/mahzi-therapeutics-announces-fda-rare-pediatric-disease-designation-for-mz-1866-investigational-therapy-for-pitt-hopkins-syndrome-302857468.html |

Independent sources: biobase.whitefordresearch.com, biopharminternational.com, kingscrowd.com, prnewswire.com, thenyledger.com

## Technologies

- [Crowdfunding & retail investment in biotech](https://en.bioecon.ru/technology/crowdfunding-retail-investment-biotech/)